Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Humanized CD7 CAR T-cell Therapy for R/R CD7+ T Cell Lymphoma

NCT05059912 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Soochow University as lead sponsor.

NCT NCT05059912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05059912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Humanized CD7 CAR T-cell Therapy for R/R CD7+ T Cell Lymphoma
Lead sponsor
The First Affiliated Hospital of Soochow University
Phase
Phase 2
Overall status
Unknown status
Start date
August 5, 2021
Completion date
August 3, 2024
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory and relapsed t cell lymphoma